CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 4/A Open-market buy Director bought 2,338 shares at an average $12.84 ($30,028)
- 4 Planned sale Director sold 100,000 shares at $44.23 ($4,422,800)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 4 Grant or award Director acquired 6,589 shares (grant or award)
- 144 Insider Sale of Securities
Page 10 of 42 · 834 filings